This book covers a number of engineered nanotheranostics platforms and nanomedicines applications of FDA-approved medicines for early-stage diagnosis and treatment of cancer. The book focuses on (i) the basic design and bioengineering of safe medicines, (ii) physicochemical understanding of surface engineered medicines and their characteristics, (iii) various examples for site-specific bioimaging and multimode therapies, (iv) stimuli-responsive approaches for targeted drug delivery applications, (v) targeted therapeutics approaches for cancer cells or solid tumor ablations, (vi) targeted mechanisms of administrative biomedicines, (vii) impact of surface modification or engineering of biomedicines for site-selective tumor binding ability, and (vii) requirements for clinical trials and FDA approval. The content of this book appeal to readers who are interested in recent developments of FDA-approved cost-effective rapid cancer imaging and therapeutic platforms.
Les informations fournies dans la section « Synopsis » peuvent faire référence à une autre édition de ce titre.
Madhusudhan Alle is currently working as Postdoc Fellow at The University of Memphis, TN, USA. Earlier he worked as Research Professor at Department of Biomedical Science & Institute of Bioscience and Biotechnology, Kangwon National University, South Korea (2018-2022), and also worked as Associate Professor at Department of Chemistry, Gondar University, Gondar, Ethiopia (2014-2018). During this period, he served as Coordinator of M.Sc. (Chemistry) Programs and as Head of the Chemistry Department. Four students submitted their master's thesis under his supervision. He received his doctorate from Department of Chemistry, Osmania University, India (2013), where he worked on the research projects sponsored by University Grants Commission, India. He has more than 20 years of experience in teaching and research in both academia and industry. He has published more than 70 scientific papers in SCI/SCIE-grade journals^2000 citations; h-index = 23) as First and Corresponding Author and published1 book and 11 chapters (Springer and Elsevier).
Shiv Dutt Purohit is currently working as International Research Professor (Assistant Professor) at the School of Chemical Engineering, Yeungnam University, Gyeongsan, South Korea. He obtained his Ph.D. from the Department of Polymer and Process Engineering, Indian Institute of Technology Roorkee, in 2021. He is Materials Scientist, and his research interests lie in biomedical and related areas such as tissue engineering and wound healing. Besides, he is also intrigued to work in other areas such as food packaging materials. He has published more than 20 research articles and chapters and has more than 500 citations on his name with an h-index of 10. He is also Reputed Reviewer for several peer-reviewed international journals and working as Academic Editor for Scientifica-Hindawi. He is also involved in the editing of a few special issues in SCIE journals.
Rajendra Prasad is currently working as Assistant Professor at the School of Biochemical Engineering, Indian Institute of Technology (BHU), Varanasi, India. Prior to this position, Rajendra Prasad had postdoctoral trainings from Tufts University, Medford, Boston, MA, USA, NOVA Medical School, Faculdade de Ciências Médicas Campo Mártires da Pátria, Lisboa, Portugal and Technion-Israel Institute of Technology, Haifa, Israel, and Indian Institute of Technology, Bombay, India, in the area of Cancer NanoMedicine and targetable cancer theranostics. Moreover, Rajendra Prasad had a chance to help few master students during my postdoctoral trainings, which gave me a confidence to handle scientific challenges and lead independent research projects. Rejendra Prasad has also cracked prestigious Postdoctoral Fellowships such as IPDF, PBC, and JSPS and hold my membership for Royal Society of Chemistry.
Azamal Husen served as Professor and Head of the Department of Biology, University of Gondar, Ethiopia, and is Foreign Delegate at Wolaita Sodo University, Wolaita, Ethiopia. Previously, he was Visiting Faculty of the Forest Research Institute and the Doon College of Agriculture and Forest at Dehra Dun, India. His research and teaching experience of 20 years encompasses the biogenic nanomaterial fabrication and application, plant responses to nanomaterials, plant adaptation to harsh environments at the physiological, biochemical, and molecular levels, herbal medicine, and clonal propagation for improvement of tree species. To his credit are over 200 publications; and he is Editor-in-Chief of the American Journal of Plant Physiology. He is also working as Series Editor of 'Exploring Medicinal Plants', published by Taylor & Francis Group, USA; 'Plant Biology, Sustainability, and Climate Change', published by Elsevier, USA; and 'Smart Nanomaterials Technology', published by Springer Nature Singapore Pte Ltd. Singapore.
Les informations fournies dans la section « A propos du livre » peuvent faire référence à une autre édition de ce titre.
Vendeur : Brook Bookstore On Demand, Napoli, NA, Italie
Etat : new. Questo è un articolo print on demand. N° de réf. du vendeur ELPYOZ2MSB
Quantité disponible : Plus de 20 disponibles
Vendeur : moluna, Greven, Allemagne
Etat : New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Covers nanotheranostics platforms and nanomedicines applications for early-stage diagnosis and treatment of cancerAddress the recent challenges of nanosized biomedicine especially for targeted imaging and therapeutics of solid tumorsProvide. N° de réf. du vendeur 1071298187
Quantité disponible : Plus de 20 disponibles
Vendeur : BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Allemagne
Buch. Etat : Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -This book covers a number of engineered nanotheranostics platforms and nanomedicines applications of FDA-approved medicines for early-stage diagnosis and treatment of cancer. The book focuses on (i) the basic design and bioengineering of safe medicines, (ii) physicochemical understanding of surface engineered medicines and their characteristics, (iii) various examples for site-specific bioimaging and multimode therapies, (iv) stimuli-responsive approaches for targeted drug delivery applications, (v) targeted therapeutics approaches for cancer cells or solid tumor ablations, (vi) targeted mechanisms of administrative biomedicines, (vii) impact of surface modification or engineering of biomedicines for site-selective tumor binding ability, and (vii) requirements for clinical trials and FDA approval. The content of this book appeal to readers who are interested in recent developments of FDA-approved cost-effective rapid cancer imaging and therapeutic platforms. 424 pp. Englisch. N° de réf. du vendeur 9789819965960
Quantité disponible : 2 disponible(s)
Vendeur : GreatBookPrices, Columbia, MD, Etats-Unis
Etat : As New. Unread book in perfect condition. N° de réf. du vendeur 46855663
Quantité disponible : Plus de 20 disponibles
Vendeur : GreatBookPrices, Columbia, MD, Etats-Unis
Etat : New. N° de réf. du vendeur 46855663-n
Quantité disponible : Plus de 20 disponibles
Vendeur : Grand Eagle Retail, Bensenville, IL, Etats-Unis
Hardcover. Etat : new. Hardcover. This book covers a number of engineered nanotheranostics platforms and nanomedicines applications of FDA-approved medicines for early-stage diagnosis and treatment of cancer. The book focuses on (i) the basic design and bioengineering of safe medicines, (ii) physicochemical understanding of surface engineered medicines and their characteristics, (iii) various examples for site-specific bioimaging and multimode therapies, (iv) stimuli-responsive approaches for targeted drug delivery applications, (v) targeted therapeutics approaches for cancer cells or solid tumor ablations, (vi) targeted mechanisms of administrative biomedicines, (vii) impact of surface modification or engineering of biomedicines for site-selective tumor binding ability, and (vii) requirements for clinical trials and FDA approval. The content of this book appeal to readers who are interested in recent developments of FDA-approved cost-effective rapid cancer imaging and therapeutic platforms. Shipping may be from multiple locations in the US or from the UK, depending on stock availability. N° de réf. du vendeur 9789819965960
Quantité disponible : 1 disponible(s)
Vendeur : buchversandmimpf2000, Emtmannsberg, BAYE, Allemagne
Buch. Etat : Neu. This item is printed on demand - Print on Demand Titel. Neuware -This book covers a number of engineered nanotheranostics platforms and nanomedicines applications of FDA-approved medicines for early-stage diagnosis and treatment of cancer. The book focuses on (i) the basic design and bioengineering of safe medicines, (ii) physicochemical understanding of surface engineered medicines and their characteristics, (iii) various examples for site-specific bioimaging and multimode therapies, (iv) stimuli-responsive approaches for targeted drug delivery applications, (v) targeted therapeutics approaches for cancer cells or solid tumor ablations, (vi) targeted mechanisms of administrative biomedicines, (vii) impact of surface modification or engineering of biomedicines for site-selective tumor binding ability, and (vii) requirements for clinical trials and FDA approval. The content of this book appeal to readers who are interested in recent developments of FDA-approved cost-effective rapid cancer imaging and therapeutic platforms.Springer-Verlag KG, Sachsenplatz 4-6, 1201 Wien 424 pp. Englisch. N° de réf. du vendeur 9789819965960
Quantité disponible : 1 disponible(s)
Vendeur : Books Puddle, New York, NY, Etats-Unis
Etat : New. 1st ed. 2024 edition NO-PA16APR2015-KAP. N° de réf. du vendeur 26398954912
Quantité disponible : 4 disponible(s)
Vendeur : AHA-BUCH GmbH, Einbeck, Allemagne
Buch. Etat : Neu. Druck auf Anfrage Neuware - Printed after ordering - This book covers a number of engineered nanotheranostics platforms and nanomedicines applications of FDA-approved medicines for early-stage diagnosis and treatment of cancer. The book focuses on (i) the basic design and bioengineering of safe medicines, (ii) physicochemical understanding of surface engineered medicines and their characteristics, (iii) various examples for site-specific bioimaging and multimode therapies, (iv) stimuli-responsive approaches for targeted drug delivery applications, (v) targeted therapeutics approaches for cancer cells or solid tumor ablations, (vi) targeted mechanisms of administrative biomedicines, (vii) impact of surface modification or engineering of biomedicines for site-selective tumor binding ability, and (vii) requirements for clinical trials and FDA approval. The content of this book appeal to readers who are interested in recent developments of FDA-approved cost-effective rapid cancer imaging and therapeutic platforms. N° de réf. du vendeur 9789819965960
Quantité disponible : 1 disponible(s)
Vendeur : Majestic Books, Hounslow, Royaume-Uni
Etat : New. Print on Demand. N° de réf. du vendeur 397422207
Quantité disponible : 4 disponible(s)